Ann: Trading Halt, page-5

Maybe they are wanting to avoid the bloodbath today?

In the past they have had trading halts for acquisitions, signings or SPP - but not likely SPP this time as just completed one and have $12m in the bank.

Could relate to one of these key milestones for 2018 in the last investor presentation (note quarters are for CY):
* Mernova Medicinal facility comes online for medicinal cannabis and adult recreational market delivering first revenues in Canada [expected May 2018]
* First revenues from cannaQIX®10 in the area of anxiety and stress from Q2 launch in Switzerland and Q3 launch in the UK
* Introduction of cannaQIX® 50 to Australia and New Zealand markets in Q3 2018
* Launch additional anibidiol® (animal health) formulations in Switzerland with potential for expansion into other countries
* Expansion of cannaQIX commercialisation into targeted, key European countries
* First product launches from Lifestyle portfolio including cannabis derived beverages and cannabis terpene chocolates into various markets delivering initial revenues
* First revenues from Kunna S.A.S, Columbian subsidiary in Q4 2018